Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Padrin
2. Prifinium
3. Pyrodifenium Bromide
1. 4630-95-9
2. Padrin
3. Riabal
4. 3-(diphenylmethylene)-1,1-diethyl-2-methylpyrrolidin-1-ium Bromide
5. Pyrodifenium Bromide
6. Pyrrolidinium, 3-(diphenylmethylene)-1,1-diethyl-2-methyl-, Bromide
7. Prifinium (bromide)
8. 3-(diphenylmethylene)-1-ethyl-2-methylpyrrolidine Ethyl Bromide
9. Chebi:32052
10. 3b7o9zc520
11. 3-benzhydrylidene-1,1-diethyl-2-methylpyrrolidin-1-ium Bromide
12. 3-benzhydrylidene-1,1-diethyl-2-methylpyrrolidin-1-ium;bromide
13. Prifinio Bromuro
14. Prifinio Bromuro [dcit]
15. Prifinii Bromidum
16. Bromuro De Prifinio
17. Bromure De Prifinium
18. Prifinium Bromide [inn:jan]
19. Prifinii Bromidum [inn-latin]
20. Bromure De Prifinium [inn-french]
21. Bromuro De Prifinio [inn-spanish]
22. Ncgc00183859-01
23. Einecs 225-051-8
24. Unii-3b7o9zc520
25. Padrin (tn)
26. 1,1-diethyl-2-methyl-3-diphenylmethylenepyrrolidinium Bromide
27. Dsstox_cid_3508
28. Dsstox_rid_77057
29. Dsstox_gsid_23508
30. Schembl24783
31. Prifinium Bromide (jan/inn)
32. Prifinium Bromide [mi]
33. Prifinium Bromide [inn]
34. Prifinium Bromide [jan]
35. 5-fluoro-5-deoxyuridine
36. Chembl1213353
37. Dtxsid3023508
38. Prifinium Bromide [mart.]
39. Prifinium Bromide [who-dd]
40. Tox21_113295
41. Mfcd00865211
42. Pyrrolidinium, 1,1-diethyl-3-diphenylmethylene-2-methyl-, Bromide
43. Akos015896351
44. Ds-7785
45. Cas-4630-95-9
46. Hy-122086
47. Cs-0081698
48. Ft-0657079
49. D01377
50. A827026
51. A1-01943
52. Q2109656
53. 3-(diphenylmethylidene)-1,1-diethyl-2-methylpyrrolidinium Bromide
54. Pyrrolidinium, 3-(diphenylmethylene)-1,1-diethyl-2-methyl-, Bromide (1:1)
Molecular Weight | 386.4 g/mol |
---|---|
Molecular Formula | C22H28BrN |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 4 |
Exact Mass | 385.14051 g/mol |
Monoisotopic Mass | 385.14051 g/mol |
Topological Polar Surface Area | 0 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 386 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AB - Synthetic anticholinergics, quaternary ammonium compounds
A03AB18 - Prifinium bromide
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Tunisia
Brand Name : Prifal 30
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging : 20/pack
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Tunisia
Regulatory Info :
Registration Country : Tunisia
Brand Name : Prifal 30
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging : 10 /pack
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Tunisia
Regulatory Info :
Registration Country : Tunisia
Brand Name : Prifal children
Dosage Form : Oral suspension
Dosage Strength : 2MG/0.4ML
Packaging : 50ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Tunisia
Regulatory Info :
Registration Country : Tunisia
Brand Name : Prifal 30
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging : 20/pack
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Tunisia
Packaging : 20/pack
Regulatory Info :
Dosage : Tablet
Dosage Strength : 30MG
Brand Name : Prifal 30
Approval Date :
Application Number :
Registration Country : Tunisia
Regulatory Info :
Registration Country : Tunisia
Brand Name : Prifal 30
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging : 10 /pack
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Tunisia
Packaging : 10 /pack
Regulatory Info :
Dosage : Tablet
Dosage Strength : 30MG
Brand Name : Prifal 30
Approval Date :
Application Number :
Registration Country : Tunisia
Regulatory Info :
Registration Country : Tunisia
Brand Name : Prifal children
Dosage Form : Oral suspension
Dosage Strength : 2MG/0.4ML
Packaging : 50ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Tunisia
Packaging : 50ml
Regulatory Info :
Dosage : Oral suspension
Dosage Strength : 2MG/0.4ML
Brand Name : Prifal children
Approval Date :
Application Number :
Registration Country : Tunisia
ABOUT THIS PAGE
A Prifinium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prifinium Bromide, including repackagers and relabelers. The FDA regulates Prifinium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prifinium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prifinium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Prifinium Bromide supplier is an individual or a company that provides Prifinium Bromide active pharmaceutical ingredient (API) or Prifinium Bromide finished formulations upon request. The Prifinium Bromide suppliers may include Prifinium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Prifinium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Prifinium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prifinium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prifinium Bromide GMP manufacturer or Prifinium Bromide GMP API supplier for your needs.
A Prifinium Bromide CoA (Certificate of Analysis) is a formal document that attests to Prifinium Bromide's compliance with Prifinium Bromide specifications and serves as a tool for batch-level quality control.
Prifinium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Prifinium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prifinium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Prifinium Bromide EP), Prifinium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prifinium Bromide USP).
LOOKING FOR A SUPPLIER?